Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2016 Apr 11;63(4):729–743. doi: 10.1016/S0025-7125(16)31671-6

Multiple Sclerosis: A Critical Update

Charles M Poser *,**
PMCID: PMC7131215  PMID: 381806

The content is available as a PDF (2.2 MB).

References

  • 1.Antel J.P., Weinrich M., Arnason B.G.W. Mitogen responsiveness and sup-pressor cell function in multiple sclerosis. Neurology. 1978;28:999–1003. doi: 10.1212/wnl.28.10.999. [DOI] [PubMed] [Google Scholar]
  • 2.Arnason B.G.W. Histocompatibility types and measles antibodies in multiple sclerosis and optic neuritis. J. Neurol. Sci. 1974;22:419–428. doi: 10.1016/0022-510x(74)90078-1. [DOI] [PubMed] [Google Scholar]
  • 3.Burks J.S. NMSS Med. Dept. 1978. A possible corona virus isolation from MS autopsy material. Memo No.97-78, Sept, 8. [Google Scholar]
  • 4.Bynke H., Olsson J.E., Rosen I. Diagnostic value of visual evoked response, clinical eye examination and CSF analysis in chronic myelopathy. Acta Neurol. Scand. 1977;56:55–69. doi: 10.1111/j.1600-0404.1977.tb01409.x. [DOI] [PubMed] [Google Scholar]
  • 5.Cala L.A., Mastaglia F.L., Black J.L. Computerized tomography of brain and optic nerve in multiple sclerosis. J. Neurol. Sci. 1978;36:411–426. doi: 10.1016/0022-510x(78)90048-5. [DOI] [PubMed] [Google Scholar]
  • 6.Carp R., Merz G., Licursi P. A non-cytopathic infectious agent associated with MS material. Neurology. 1975;25:492–493. [PubMed] [Google Scholar]
  • 7.Cohen S.R., Herndon R.M., McKhann G.M. Radioimmunoassay of myelin basic protein in spinal fluid. New Engl. J. Med. 1976;295:1455–1457. doi: 10.1056/NEJM197612232952604. [DOI] [PubMed] [Google Scholar]
  • 8.Cohn H. Appraisal of the PAM cell effect as a diagnostic test for multiple sclerosis. Ann. Neurol. 1978;3:400–402. doi: 10.1002/ana.410030506. [DOI] [PubMed] [Google Scholar]
  • 9.Compston A. HLA and neurologic disease. Neurology. 1978;28:413–414. doi: 10.1212/wnl.28.5.413. [DOI] [PubMed] [Google Scholar]
  • 10.Cook S. Further evidence of a possible association between house dogs and multiple sclerosis. Ann. Neurol. 1978;3:141–143. doi: 10.1002/ana.410030209. [DOI] [PubMed] [Google Scholar]
  • 11.Eldridge R., McFarland H., Sever J. Familial multiple sclerosis: clinical histo-compatibility and viral serological studies. Ann. Neurol. 1978;3:72–80. doi: 10.1002/ana.410030111. [DOI] [PubMed] [Google Scholar]
  • 12.Ellison G.W., Myers L.W. A review of systemic nonspecific immunosuppressive treatment of multiple sclerosis. Neurology. 1978;28(2):132–139. doi: 10.1212/wnl.28.9_part_2.132. [DOI] [PubMed] [Google Scholar]
  • 13.Feldman R. Baclofen for spasticity in multiple sclerosis. Neurology. 1978;28:1094–1098. doi: 10.1212/wnl.28.11.1094. [DOI] [PubMed] [Google Scholar]
  • 14.Fewster M.E. Histocompatibility types and measles antibodies in multiple sclerosis. J. Neurol. Sci. 1977;34:287–296. doi: 10.1016/0022-510x(77)90076-4. [DOI] [PubMed] [Google Scholar]
  • 15.Fog T. Long-term transfer factor treatment for multiple sclerosis. Lancet. 1978;1:851–853. doi: 10.1016/s0140-6736(78)90194-0. [DOI] [PubMed] [Google Scholar]
  • 16.Fuccillo D.A. Multiple sclerosis: Cellular and humoral immune responses to several viruses. Neurology. 1978;28:613–615. doi: 10.1212/wnl.28.6.613. [DOI] [PubMed] [Google Scholar]
  • 17.Ghatak N.R. Asymptomatic demyelinated plaques in the spinal cord. Arch. Neurol. 1974;30:484–486. doi: 10.1001/archneur.1974.00490360060012. [DOI] [PubMed] [Google Scholar]
  • 18.Gutstein H.S., Cohen S.R. Spinal fluid differences in experimental allergic encephalomyelitis and multiple sclerosis. Science. 1978;199:301–303. doi: 10.1126/science.619457. [DOI] [PubMed] [Google Scholar]
  • 19.Halliday A., McDonald W., Mushin J. Visual evoked response in diagnosis of multiple sclerosis. Brit. Med. J. 1973;4:661–664. doi: 10.1136/bmj.4.5893.661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Henle G. Multiple sclerosis associated agent. Infect. Immun. 1975;12:1367–1374. doi: 10.1128/iai.12.6.1367-1374.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kurtzke J.F. Geography in multiple sclerosis. J. Neurol. 1977;215:1–26. doi: 10.1007/BF00312546. [DOI] [PubMed] [Google Scholar]
  • 22.Levy N., Auerbach P., Hayes E. A blood test for multiple sclerosis based on the adherence of lymphocytes to measles infected cells. New Eng. J. Med. 1976;294:1423–1427. doi: 10.1056/NEJM197606242942604. [DOI] [PubMed] [Google Scholar]
  • 23.Lisak R.P. Cell mediated immunity to measles, myelin basic protein, and central nervous system extract in multiple sclerosis. Neurology. 1978;28:798–803. doi: 10.1212/wnl.28.8.798. [DOI] [PubMed] [Google Scholar]
  • 24.Lowitzsch K. Visual evoked responses and blink reflexes in assessment of MS diagnosis. J. Neurol. 1976;213:117–132. doi: 10.1007/BF00316336. [DOI] [PubMed] [Google Scholar]
  • 25.Madden D.L. Multiple sclerosis associated agent (MSAA): Failure to confirm an association with multiple sclerosis. Neurology. 1978;28:295–299. doi: 10.1212/wnl.28.3.295. [DOI] [PubMed] [Google Scholar]
  • 26.Mastaglia F. Evoked potentials, saccadic velocities, and computerized tomography in diagnosis of multiple sclerosis. Brit. Med. J. 1977;1:1315–1317. doi: 10.1136/bmj.1.6072.1315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.McSherry, J., and O'Brien, P.: Visual evoked responses in multiple sclerosis. In press
  • 28.Mitchell D.N. Isolation of an infectious agent from bone marrows of patients with multiple sclerosis. Lancet. 1978;2:387–391. doi: 10.1016/s0140-6736(78)91862-7. [DOI] [PubMed] [Google Scholar]
  • 29.Murray S., Veidlinger O.F. Serial radionuclide scans in multiple sclerosis. Can. J. Neurol. Sci. 1978;5:321–323. doi: 10.1017/s0317167100024410. [DOI] [PubMed] [Google Scholar]
  • 30.Nathanson N., Paulsson P., Gudmundsson G. Multiple sclerosis and canine dis-temper in Iceland. Lancet. 1978;2:1127–1129. doi: 10.1016/s0140-6736(78)92279-1. [DOI] [PubMed] [Google Scholar]
  • 31.Offner H., Konat G., Clausen J. A blood test for multiple sclerosis. New Engl. J. Med. 1977;296:451–454. doi: 10.1056/NEJM197702242960814. [DOI] [PubMed] [Google Scholar]
  • 32.Paty D.W. HLA in multiple sclerosis. Relationship to measles antibody, mi-togen responsiveness and clinical course. J. Neurol., Sci. 1977;32:371–379. doi: 10.1016/0022-510x(77)90020-x. [DOI] [PubMed] [Google Scholar]
  • 33.Peyser, J., Edwards, K., and Poser, C.: Cognitive function in multiple sclerosis patients. Arch Neurol., in press [DOI] [PubMed]
  • 34.Poser C. Multiple Sclerosis. In: Tower D., editor. The Nervous System. Raven Press; New York: 1975. pp. 337–345. Vol. 2. [Google Scholar]
  • 35.Poser C. Multiple Sclerosis. In: Baker A., Baker L., editors. Clinical Neurology. Harper and Row; New York: 1978. pp. 1–70. Vol. 2, Chap. 25. [Google Scholar]
  • 36.Poser, C. M.: Stress, trauma and multiple sclerosis. Bull. Am. Acad. Psychiat. Law, in press
  • 37.Poser C., Roman G., Emery E. Recurrent disseminated vasculomyelinopathy. Arch. Neurol. 1978;35:166–170. doi: 10.1001/archneur.1978.00500270048010. [DOI] [PubMed] [Google Scholar]
  • 38.Raine C.S. Immunocytochemical studies for the localization of measles an-tigens in multiple sclerosis plaques and measles virus-infected CNS tissue. J. Neurol. Sci. 1977;33:13–20. doi: 10.1016/0022-510x(77)90177-0. [DOI] [PubMed] [Google Scholar]
  • 39.Robinson K., Rudge P. Auditory evoked response in multiple sclerosis. Lancet. 1975;1:1164–1166. doi: 10.1016/s0140-6736(75)93138-4. [DOI] [PubMed] [Google Scholar]
  • 40.Schmidt R., Rieder H.P., Wutrich R. The course of multiple sclerosis cases with extremely high y-globulin values in the cerebrospinal fluid. Eur. Neurol. 1977;15:241–248. doi: 10.1159/000114809. [DOI] [PubMed] [Google Scholar]
  • 41.Schumacher G. Critique of experimental trials of therapy in multiple sclerosis. Neurology. 1974;24:1010–1014. doi: 10.1212/wnl.24.11.1010. [DOI] [PubMed] [Google Scholar]
  • 42.Sears E.S., Tindall R.S.A., Zarnow H. Active multiple sclerosis: enhanced computerized tomographic imaging lesions and the effect of corticosteroids. Arch. Neurol. 1978;35:426–434. doi: 10.1001/archneur.1978.00500310028006. [DOI] [PubMed] [Google Scholar]
  • 43.Seil F.J. Tissue culture studies of demyelinating disease: a critical review. Ann. Neurol. 1977;2:345–355. doi: 10.1002/ana.410020417. [DOI] [PubMed] [Google Scholar]
  • 44.Sylwester D., Poser C. Multiple sclerosis, domestic animals and household pets. Ann. Neurol. 1979;5:207–208. doi: 10.1002/ana.410050220. [DOI] [PubMed] [Google Scholar]
  • 45.Symington G.R., Mackay I.R. Cell-mediated immunity to measles virus in mul-tiple sclerosis: correlation with disability. Neurology. 1978;28:109–112. doi: 10.1212/wnl.28.2.109. [DOI] [PubMed] [Google Scholar]
  • 46.Thygesen P. The course of disseminated sclerosis: A close-up of 105 attacks. Rosenkilde and Bagger; Copenhagen: 1953. pp. 71–93. 141-142. [Google Scholar]
  • 47.Whitaker J.N. The distribution of myelin basic protein in central nervous system lesions of multiple sclerosis and acute experimental allergic encephalomyelitis. Ann. Neurol. 1978;3:291–298. doi: 10.1002/ana.410030403. [DOI] [PubMed] [Google Scholar]
  • 48.Williams A.C. Increased CSF IgM in multiple sclerosis. Neurology. 1978;28:996–998. doi: 10.1212/wnl.28.10.996. [DOI] [PubMed] [Google Scholar]
  • 49.Wisniewski H.M., Keith A.B. Chronic relapsing experimental allergic encepha-lomyelitis: An experimental model of multiple sclerosis. Ann. Neurol. 1977;1:144–148. doi: 10.1002/ana.410010207. [DOI] [PubMed] [Google Scholar]
  • 50.Wuthrich R. CT scanning in demyelinating disease. In: Laubsch, Razner, editors. In Cranial Computerized Tomography. Verlag; Springer: 1976. pp. 239–243. [Google Scholar]

Articles from The Medical Clinics of North America are provided here courtesy of Elsevier

RESOURCES